Wellnex Life (ASX:WNX) announced its unaudited half-year financial results for the period ended Dec. 31, 2025.
Under the leadership of Executive Chairman Ash Vesali, the company executed a strategic turnaround focused on enhancing management processes and implementing tighter capital controls.
The initiatives yielded financial improvements, most notably an 8% increase in revenue to $12.9 million for the first half of FY25.
The company's drive for operational excellence is further reflected in its profitability metrics.
Gross margins saw a substantial boost, rising by 9.4 percentage points compared to the prior period to reach 32.1%.
A critical milestone was achieved in the second quarter of the 2026 financial year, during which the business reached operating breakeven.
The achievement provides the group with positive momentum as it enters the latter half of the fiscal year.
Wellnex Life remains focused on sustaining the performance to build long-term shareholder value.
Following the close of the reporting period, the company has commenced a review of various funding options to raise capital.
The funds are intended to support general operations and facilitate the settlement of related party loans.
As the company moves into H2 FY26, the board maintains a clear focus on delivering consistent results through its revitalised, cost-efficient framework.